What will a GLP-1 cost me?
Free. Nothing you enter leaves your browser. Checked October 18, 2026.
Paying yourself: every medicine, every dose
The makers' own self-pay prices for a month's supply. Enter a monthly budget to see which fit.
| Medicine and dose | Month | Year | Year, from an HSA/FSA |
|---|---|---|---|
| Zepbound 2.5 mg | $299 | $3,887 | $3,032 |
| Zepbound 5 mg | $399 | $5,187 | $4,046 |
| Zepbound 7.5 mg if refilled within 45 days, otherwise $499 | $449 | $5,837 | $4,553 |
| Zepbound 10 mg if refilled within 45 days, otherwise $699 | $449 | $5,837 | $4,553 |
| Zepbound 12.5 mg if refilled within 45 days, otherwise $699 | $449 | $5,837 | $4,553 |
| Zepbound 15 mg if refilled within 45 days, otherwise $699 | $449 | $5,837 | $4,553 |
| Wegovy 0.25 mg $199 for the first 2 fills if new to Wegovy, through 31 December 2026 | $349 | $4,537 | $3,539 |
| Wegovy 0.5 mg $199 for the first 2 fills if new to Wegovy, through 31 December 2026 | $349 | $4,537 | $3,539 |
| Wegovy 1 mg | $349 | $4,537 | $3,539 |
| Wegovy 1.7 mg | $349 | $4,537 | $3,539 |
| Wegovy 2.4 mg | $349 | $4,537 | $3,539 |
| Wegovy 7.2 mg (HD) | $399 | $5,187 | $4,046 |
| Wegovy pill 1.5 mg | $149 | $1,788 | $1,395 |
| Wegovy pill 4 mg | $199 | $2,388 | $1,863 |
| Wegovy pill 9 mg | $299 | $3,588 | $2,799 |
| Wegovy pill 25 mg | $299 | $3,588 | $2,799 |
| Foundayo 0.8 mg | $149 | $1,788 | $1,395 |
| Foundayo 2.5 mg offer price through 31 December 2026; regular price $199 | $149 | $1,788 | $1,395 |
| Foundayo 5.5 mg offer price through 31 December 2026; regular price $299 | $199 | $2,388 | $1,863 |
| Foundayo 9 mg | $299 | $3,588 | $2,799 |
| Foundayo 14.5 mg if refilled within 45 days, otherwise $349 | $299 | $3,588 | $2,799 |
| Foundayo 17.2 mg if refilled within 45 days, otherwise $349 | $299 | $3,588 | $2,799 |
| Mounjaro Any dose | $499 | $6,487 | $5,060 |
| Ozempic 0.25 mg $199 for the first 2 fills if new, through 31 December 2026 | $349 | $4,537 | $3,539 |
| Ozempic 0.5 mg $199 for the first 2 fills if new, through 31 December 2026 | $349 | $4,537 | $3,539 |
| Ozempic 1 mg | $349 | $4,537 | $3,539 |
| Ozempic 2 mg | $499 | $6,487 | $5,060 |
| Ozempic tablets 1.5 mg | $149 | $1,788 | $1,395 |
| Ozempic tablets 4 mg | $199 | $2,388 | $1,863 |
| Ozempic tablets 9 mg | $299 | $3,588 | $2,799 |
Year figures use 13 fills for weekly injections (a box lasts 28 days) and 12 for monthly bottles of tablets. The HSA/FSA column takes off federal income tax at the rate you chose and nothing else; it only applies if the costs qualify, which the IRS limits to treatment of a diagnosed disease such as obesity.
Prices that change on 1 January 2027
- Lilly's savings card terms, the Zepbound and Foundayo refill prices and the Foundayo offer prices end on 31 December 2026.
- Novo Nordisk's $199 starter price for new Wegovy and Ozempic patients ends on 31 December 2026.
- Novo Nordisk cuts the list price of Wegovy, Ozempic and Rybelsus to $675 a month. It says self-pay prices do not change.
What TrumpRx.gov is
Launched on 5 February 2026, it lists out-of-pocket prices for Wegovy, Ozempic, Zepbound vials and Foundayo and passes your order to the maker. On 18 October 2026 its prices matched LillyDirect and NovoCare exactly. If you have insurance, check your copay first.
About compounded semaglutide and tirzepatide
Compounded versions are often cheaper, and the rules around them have tightened. This is where they stand:
- The FDA declared the tirzepatide shortage over on 19 December 2024 and the semaglutide shortage over on 21 February 2025. The grace periods for compounding pharmacies ended in spring 2025.
- On 6 February 2026 the FDA said it would restrict GLP-1 ingredients in non-approved compounded drugs, and on 3 March 2026 it sent warning letters to 30 telehealth companies over how they marketed them.
- Compounded versions are not FDA-approved, may not be called generic or the same as the approved drug, and some use salt forms of semaglutide that are a different active ingredient.
- On 30 April 2026 the FDA proposed removing semaglutide, tirzepatide and liraglutide from the list larger outsourcing facilities can compound from. No final decision had been published by 18 October 2026.
Spending less without changing medicine
- Refill on time. Several Lilly prices are lower only if the next fill comes within 45 days.
- Ask whether your plan covers it for another approved use: heart risk, sleep apnea or fatty liver for Wegovy and Zepbound, type 2 diabetes for Ozempic and Mounjaro.
- If your plan says no, appeal. The appeal letter writer drafts one.
- Use pre-tax money. Prescription drugs count as medical expenses. Weight-loss costs count only when they treat a specific disease diagnosed by a physician, such as obesity, high blood pressure or heart disease, not for general health or appearance. Drugs imported from other countries generally do not count.
Questions people ask
What is the cheapest way to get Zepbound without insurance?
Lilly's self-pay prices through LillyDirect, for the KwikPen or vials, are $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg if you refill within 45 days. TrumpRx.gov lists the same prices and sends the order to Lilly.
How much is Wegovy without insurance?
NovoCare Pharmacy sells Wegovy pens for $349 a month at every dose up to 2.4 mg and $399 for the 7.2 mg HD pen, with $199 for the first two fills of the starting doses for new patients through 31 December 2026. The Wegovy pill is $149 to $299 a month depending on the dose.
Can I use a manufacturer coupon with Medicare?
No. Savings cards exclude Medicare, Medicaid, VA and TRICARE. Medicare's own route is the GLP-1 Bridge: $50 a fill for eligible people from 1 July 2026 to 31 December 2027.
Can I pay for a GLP-1 with my HSA or FSA?
Usually, when it is prescribed to treat a diagnosed disease such as obesity, high blood pressure or heart disease. IRS Publication 502 excludes weight loss for general health or appearance. Check with your plan administrator.
More free tools
- How to get a GLP-1 in the USYour route from first question to first dose, for your coverage.
- Eligibility checkYour BMI against the criteria the trials, labels and Medicare use.
- Insurance checkerWhat your kind of plan usually covers, and what to ask.
- Appeal letter writerA denial letter answered, ready to send. Nothing you type is stored.
- Supply and refill plannerWhen your pens run out, when to reorder, and the national supply.
- GLP-1 diet calculatorYour calories, protein and three days of food for your dose.
Sources, checked October 18, 2026
- LillyDirect: Zepbound self-pay
- Zepbound coverage and savings (Lilly)
- Foundayo coverage and savings (Lilly)
- LillyDirect: Mounjaro self-pay
- Mounjaro savings (Lilly)
- NovoCare Pharmacy self-pay
- Save on Wegovy (Novo Nordisk)
- Wegovy savings card terms (NovoCare)
- Save on Ozempic (Novo Nordisk)
- TrumpRx.gov
- White House fact sheet on the Lilly and Novo Nordisk agreements (6 November 2025)
- Novo Nordisk: US list price reduction from 1 January 2027 (24 February 2026)
- CMS: Medicare GLP-1 Bridge
- CMS: GLP-1 Bridge information for prescribers (June 2026)
- Medicare.gov: weight-loss drugs
- KFF: Medicaid coverage of and spending on GLP-1s (16 January 2026)
- IRS Publication 502, medical and dental expenses
- FDA: policies for compounders as GLP-1 supply stabilizes
- FDA: action against non-FDA-approved GLP-1 drugs (6 February 2026)
- FDA: warning letters to 30 telehealth companies (3 March 2026)
- FDA: proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (30 April 2026)
General information for people in the United States, not medical, legal or insurance advice. Prices and plan rules change; the source links above are the final word. foodose does not prescribe, sell or dispense medicine, and is not affiliated with Novo Nordisk or Eli Lilly.